Copied from the National Ataxia Foundation.
We have received lots of questions from our community about Troriluzole, an investigational therapy for SCA. Join us on Tuesday, December 10th at 1 pm CST, for All About Troriluzole presented by Dr. Susan Perlman. In this session, we will go over some of the most common questions we have received about Troriluzole. Then there will be an open Q&A session for attendees to ask their own questions.
Troriluzole is an investigational therapy that is under evaluation and not approved by the FDA. Anyone considering participating in a clinical trial or trying a new medication should discuss the matter with their physician. The National Ataxia Foundation does not endorse or recommend particular studies or treatment options
Register here: Webinar Registration - Zoom